Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Abdul-Aziz Hassan"'
Autor:
Andre Pascal Kengne, Leon Tshilolo, Grace Ndeezi, Nicola Mulder, Moses Joloba, Victoria Nembaware, Nchangwi Syntia Munung, Vivian Paintsil, Emmanuel Peprah, Fred Stephen Sarfo, Deogratias Munube, Collen Masimirembwa, Ambroise Wonkam, Daniel Ansong, Kwaku Ohene-Frempong, Ezekiel Mupere, Sarah Kiguli, Julie Makani, Josephine Mgaya, Siana Nkya, Fred Semitala, Raphael Zozimus Sangeda, Emmanuel Balandya, Anazoeze Madu, Catherine Chunda-Liyoka, Yeya Dit Sadio Sarro, Daudi Jjingo, Obiageli Eunice Nnodu, Lulu Chirande, Boubacari Ali Touré, Aldiouma Guindo, Patience Kuona, Kevin Esoh, Mario Jonas, Maxwell Nwegbu, Upendo Masamu, Jack Morrice, Patrick Ohiani Moru, Valentina Ngo Bitoungui, Hans Ackerman, Alex Osei Akoto, Emmanuela Ambrose, Evans Amuzu, Samuel Asala, Biobele Brown, Mmbando Bruno, Daima Bukini, Pamela Gorejena, Abdul Aziz Hassan, Justin Hokororo, Jade Hotchkiss, Abdoul Malik Idris, Hezekiah Isa, Agnes Jonathan, Gwendoline Q. Kandawasvika, Daniel Kandonga, Ibrahima Keita, Sekou Kene, Frank Makundi, Janeth Manongi, Hamakwa Mantina, Jason Maro, Irene Kida Minja, Khuthala Mnika, Takudzwa Mtisi, Wilson Mupfururirwa, Ritah Mutagonda, Ruth Namazzi, Solomon Ofori-Aquah, Emmanuel Okocha, Fumni Olopade, Jesca Ondego, Chandré Oosterwyk-Liu, Nash Oyekanmi, Stella Paul, Cynthia Phiri, Paschal Ruggajo, Parker Ruhl, Ian Machingura Ruredzo, Pauline Sambo, Sawabati Shabani, Florence Urio, Robert Opoka
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Background Sickle cell disease (SCD) is a prevalent inherited blood disorder. Globally, approximately 515 000 babies are born with SCD annually, with 75% of these births occurring in Africa. Integrating newborn screening (NBS) for SCD into primary he
Externí odkaz:
https://doaj.org/article/071fae27709947318206425d2fa31a68
Publikováno v:
Ibn Al-Haitham Journal for Pure and Applied Sciences, Vol 37, Iss 1 (2024)
The attached Cyanophyta community is a model for monitoring aquatic systems and interpreting environmental change in aquatic systems. The present study aims to conduct a seasonal study on Cyanophyta attached to the concrete abutments of three bridges
Externí odkaz:
https://doaj.org/article/69eaa5dcdb80456183a1e2e80a950a1f
Autor:
Hezekiah Isa, Emmanuel Okocha, Samuel Ademola Adegoke, Uche Nnebe-Agumadu, Aisha Kuliya-Gwarzo, Alayo Sopekan, Akinyemi Olugbenga Ofakunrin, Ngozi Ugwu, Abdul-Aziz Hassan, Chinatu Ohiaeri, Anazoeze Madu, Ijeoma Diaku-Akinwumi, Lilian Ekwem, Livingstone Gayus Dogara, Dorothy Okoh, James Jasini, Ahmed Girei, Timothy Ekwere, Angela Okolo, Umar Kangiwa, Juliet Lawson, Reuben Chianumba, Biobele Brown, Norah Akinola, Maxwell Nwegbu, Obiageli Nnodu
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Background: Sickle cell disease (SCD) continues to pose physical and psychosocial burdens to patients, caregivers and health workers. Stakeholder engagement in the processes of policy making and implementation is increasingly becoming the cornerstone
Externí odkaz:
https://doaj.org/article/a8ddd0dd08ad491c80da2e340b2ef3de
Publikováno v:
المجلة الدولية للعلوم الإنسانية والاجتماعية, Iss 19 (2021)
قامت الباحثة بهذا البحث بهدف الكشف عن العلاقة بين الممارسات التربوية للوالدين في التعليم عن بعد بأبعادها المختلفة للمرحلة الإبتدائية وك
Externí odkaz:
https://doaj.org/article/26c5bde07d724dc5b277a7a430e086e7
Autor:
Ahmed, Dirar Elmahi Elobeid1 de.ahmed@qu.edu.sa, Mohammed, Khaled Abdul Aziz Hassan2 khald_aziz32@yahoo.com
Publikováno v:
Rihan Journal for Science Publishing. 2022, Issue 20, p18-42. 25p.
Autor:
Baba Psalm Duniya Inusa, Atoyebi Wale, Abdul Aziz Hassan, Tushar Idhate, Livingstone Dogara, Ifeoma Ijei, Yewen Qin, Kofi Anie, Juliana Olufunke Lawson, Lewis Hsu
Publikováno v:
F1000Research, Vol 7 (2018)
The multiple clinical benefits of hydroxycarbamide in sickle cell disease are supported by a large body of evidence. The maximum tolerated dose (MTD) is the regimen recommended by guidelines from a panel of National Heart, Lung, and Blood Institute (
Externí odkaz:
https://doaj.org/article/622768a5a34942d7ac52b4e649fc7922
Publikováno v:
Sahel Medical Journal, Vol 17, Iss 1, Pp 19-22 (2014)
Introduction: Provision of adequate safe blood is challenging in developing countries due to paucity of voluntary blood donors, poor facilities for storage and blood component preparation as well as inappropriate blood ordering and utilization. Appra
Externí odkaz:
https://doaj.org/article/375878b1354a447d8974d5b2f0734986
Publikováno v:
Sahel Medical Journal, Vol 16, Iss 1, Pp 1-4 (2013)
Background: Prothrombin time (PT) and activated partial thromboplastin time (APTT) are the tests used in the investigation and monitoring of hemostatic disorders. Plasma is used to perform these tests immediately or stored for later use. The time and
Externí odkaz:
https://doaj.org/article/70a892807e744329b4385346da825842
Autor:
Hezekiah Isa, Samuel Adegoke, Anazoeze Madu, Abdul-Aziz Hassan, Chinatu Ohiaeri, Reuben Chianumba, Biobele Brown, Emmanuel Okocha, Ngozi Ugwu, Ijeoma Diaku-Akinwumi, Titilope Adeyemo, Aisha Kuliya-Gwarzo, Livingstone Dogara, Haliru Lawal, Yohanna Tanko, Adama Ladu, Umar Kangiwa, Lilian Ekwem, Seyi Oniyangi, Tambi Wakama, Domic Umoru, Olaniyi Olanrewaju, Norah Akinola, Uche Nnebe-Agumadu, Samuel Asala, Adekunle Adekile, John Olaniyi, Raphael Sangeda, null Sickle Africa Data Coordinating Center (SADaCC), Obiageli Nnodu
Publikováno v:
Blood Cells Mol Dis
Background/objective Sickle cell disease (SCD) is a monogenic disease with multiple phenotypic expressions. Previous studies describing SCD clinical phenotypes in Nigeria were localized, with limited data, hence the need to understand how SCD varies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6623c2b3ef546aee7c5615f7e2591a52
https://doi.org/10.1016/j.bcmd.2020.102438
https://doi.org/10.1016/j.bcmd.2020.102438
Autor:
Tushar Idhate, Lewis L. Hsu, Ifeoma P Ijei, Atoyebi Wale, Yewen Qin, Livingstone Gayus Dogara, Juliana Olufunke Lawson, Abdul Aziz Hassan, Kofi A. Anie, Baba Inusa
Publikováno v:
F1000Research. 7:1407
The multiple clinical benefits of hydroxycarbamide in sickle cell disease are supported by a large body of evidence. The maximum tolerated dose (MTD) is the regimen recommended by guidelines from a panel of National Heart, Lung, and Blood Institute (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d7cb04d8d0a1133632db88206a5cdd
https://doi.org/10.12688/f1000research.14589.1
https://doi.org/10.12688/f1000research.14589.1